Legislative update – Sept. 2009 — REACH, RoHS2
Summary
The legal obligations within the REACH Regulations and the potential impact of the so called “RoHS2” proposals dominate the legislative scene at present. Also, obligations are starting to filter through as part of the eco design/energy using Products Directive that monitors energy efficiency throughout a products life cycle. Going-forward, the scope of this directive will become more diverse to encompass energy related products.
Industry, and the design engineer, needs to be aware of developments and the potential impact on their companies.
REACH
Regulation 1907/2006, the Regulation, Evaluation, Authorisation -and restriction-of Chemicals (REACH) entered into force on 1 June 2007 after almost 8 years of debate and covering some 849 pages of regulation.
The only census on chemicals, taken in 1981, highlighted that 100,106 substances were placed on the market. Of those used, manufactured or imported at levels of 1000 tonnes or more, 21 percent had no safety data at all while a further 65 percent provided insufficient safe use data. Only 3 percent had been fully tested.
At the same time, instances of allergies, asthma, certain types of cancer and reproductive disorders were on the increase in Europe. Skin diseases alone resulted in the loss of 3 million working days per year.
Driven by the obligatory flow of safety data throughout the supply chain, REACH seeks to provide protection to health and the environment.
The biggest challenge to industry to date has been around the collection of data advising where a so called Substance of Very High Concern (SVHC) is present in a product, known as an article in the regulations, at a level of 0.1% by weight of the total article.
As a minimum obligation the name of the substance along with supporting safe use data must flow downstream through the supply chain.
Substances that are categorised as SVHC include those that are carcinogenic, mutagenic or toxic for reproduction. Also, substances that are persistent, liable to bio-accumulate and toxic, and finally “others” such as endocrine disrupters that can have a particular impact on aquatic life.
Back in October 2008, the first batch of 15 substances of very high concern was published by the European Chemicals Agency and, the following January, seven of these were earmarked for a consultation on whether or not they should be subject to a very costly “authorisation of use” requirement. These seven were approved and the European Commission will determine the date when these will be added to Annex XIV.
These obligations will then enter into force some 42-48 months later on what is known as the sunset date. Where such an authorisation is approved, downstream users can only use these substances for the use that they have been authorised for and they can only be purchased from the company granted the authorisation.
The REACH data collection has resulted in the circulation of hundreds of “standard letters” in a multitude of formats. Many manufacturers have refused to reply to the ad-hoc requests they receive preferring to promote websites or central databases (these have been slow to develop).
Guidance on the regulation encourages a more pro-active approach rather than simply providing a link to a website. Likewise, there have been many random requests for information that is not obligatory such as pre-registration details and RoHS style certificates of compliance.
Future batches of SVHCs will be published on an on-going basis, with the next expected early 2010, so REACH will not be a box that can be ticked as complete for several years to come.
“RoHS2”
Looking back the Restriction of Hazardous Substances (RoHS) Directive 2002/95 entered into force on 1 July 2006. It featured six restricted substances across eight broad categories of product pulled from the 10 categories in the Waste Electrical and Electronic Equipment (WEEE) Directive. There were 29 exemptions to assist manufacturers and design engineers where no viable alternative was available and a whole raft of “grey” definitions that required clarity.
“RoHS2” proposals look to move the directive forward and provide greater clarity. However, some of its provisions will potentially have cost and resource issues for industry.
The proposals recommend that the two remaining categories from the original WEEE categories, namely medical devices and monitoring and control instruments be added to the scope from 2014 (in-vitro diagnostics from 2016 and industrial “test” equipment in 2017). These were originally omitted from the directive due to reliability concerns over the use of lead-free solder.
While there are no substances actually restricted under the proposals, four are recommended for priority assessment. Three plasticisers used in a variety of applications and a flame retardant may well be restricted. Ironically, the substances, BBP, DBP, DEHP and HBCDD are four of the seven subject to authorisation of use under the REACH Regulations.
The fate of these substances under RoHS will be open to consultation after the revised directive comes into scope sometime in 2011-2012. Either way, any restriction under RoHS will probably be sooner than under the REACH process and the analysis is unlikely to be done twice.
Under a separate review by European Commission consultants, 29 exemptions will continue under the proposals, many with amended wording for clarity, 6 will be withdrawn and one new one will be granted. These could come into force next year and that will be followed by a transposition period of, on average, 18 months allowing manufacturers the time to comply.
In addition, a further six exemptions were added in June 2009 that had been proposed a year earlier.
RoHS2 also clarifies definitions such as equipment within out of scope equipment, spare parts and military where the latter clearly does not include dual use equipment.
A standard, and rigid declaration of conformity appears in annex 7 and will replace the multitude of different certificates, statements and compliance documents under the original legislation.
There now appears to be no scope for qualifying statements such as “so far as we are aware” and “to the best of our knowledge”.
It is proposed that RoHS will become a CE mark directive placing responsibilities on manufacturers, importers and distributors. There are many requirements including building technical files and keeping for 10 years, ensuring products comply, that they are supplied with the CE mark and the manufacturer or importer is identified on the product. Sample testing should also be carried out where appropriate, and corrective action is undertaken where product is found to be non compliant.
Finally under the proposals, the broad product categories and list of indicative products move from the WEEE Directive and sit in annex 1 and 2 of the RoHS Directive.
The terminology “RoHS2” is unofficial and is used simply to highlight the proposed changes to the original directive.
Energy using Products
Directive 2005/32/EC, Energy using Products, entered into force on 11 August 2007.
The main aim is to monitor energy efficiency throughout the life cycle of a product from the mining of raw material right through to recycling at end-of-life.
The focus is clearly on the design phase of the product since it is considered that this is the determining stage affecting the resources used in a product.
The directive does not apply to means of transport (planes, cars etc) but, apart from this, the scope is deliberately broad covering, in principle, any product which when in use depends on, generates, transfers or measures energy (electricity, fossil fuel or renewable).
Obligations on manufacturers will result from a series of specific “implementing measures” the first of which was adopted in January 2009.
The criteria required before a product can be considered for assessment is that is that it must sell more than 200,000 units per year in the European Union, have a significant environmental impact and present considerable potential for improvement. The latter is important as the target is for a 20% improvement in energy efficiency by 2020.
During phase one, studies were commission on 20 broad product categories ranging from water heaters, televisions and lighting, through to imaging equipment and personal computers.
Beyond that, a further 17 categories have been highlighted from ovens and hobs, machine tools and air-conditioning equipment through to transformers and networking equipment.
Among the first obligations to come in to force were energy efficiency improvements covering standby and off-mode losses, simple converter boxes for digital television, external power supplies and office, street and domestic lighting.
However, the European Parliament has now adopted the European Commission’s (EC) proposal to widen the scope of the directive to include energy related products. Until now the Energy using Products Directive was limited to products that consume energy during use such as boilers, computers, televisions, industrial fans and light bulbs.
However, many products have an indirect impact on the energy in use such as water using devices, taps and showerheads for example, and double glazing windows or insulating material.
Improvement in design could clearly result in the significant saving of energy.
For example, water saving taps and shower heads reduce water consumption and therefore the amount of energy used for hot water.
Under the EuP Directive studies had to set requirements for individual products where, in fact, it is the performance of the whole system that often needs to be optimised not just a single component or products.
The new directive will repeal the existing 2005/32/EC.
Upcoming in the SENS4 conference Schedule
Session 21 Tissue engineering (Chair: Leonid Gavrilov)
Augustinus Bader Leipzig, Germany
Currently Available Therapies with Autologous Stem Cells – From Basic Principles to Clinical Application
Gabor Forgacs Columbia, USA
Organ Engineering by Bioprinting
Biomaterials-based exogenous scaffolds, though promising, still face general as well as specific challenges. Scaffolds may elicit adverse host responses and interfere with direct cell-cell interaction, as well as assembly and alignment of cell-produced extracellular matrix. Thus, fabrication techniques for production of scaffold-free engineered tissue constructs have recently emerged. Here we describe a novel fully biological self-assembly approach, which we implement through a rapid prototyping bioprinting method. The approach utilizes bio-ink particles, convenient multicellular units, either spheroids or cylinders of controlled diameter (300 to 500 μm), that are deposited with specifically designed bio-printers. The cellular composition of the bio-ink and the deposition scheme are respectively consistent with the cellular composition and topology of the desired biological construct. We use the method for scaffold-free small diameter vascular reconstruction and nerve regeneration. Various vascular cell types, including smooth muscle cells and fibroblasts, are aggregated into the bio-ink units. These are printed layer-by-layer concomitant with agarose rods, used here as a molding template. The post-printing fusion of the discrete units results in single- and double-layered small diameter vascular tubes. A unique aspect of the method is the ability to engineer vessels of distinct shapes, complex internal geometry, in case of nerve grafts, and hierarchical trees that combine tubes of distinct diameters, in the case of vascular grafts. The technique is quick and easily scalable.
Sally Dickinson Bristol, UK
The first clinical transplantation of a tissue engineered airway
Session 22 The longer term (Chair: Augustinus Bader)
Philip Moriarty Nottingham, UK
Molecular Nanotechnology in the Real World: How Feasible is a Nanofactory?
I will critically assess MNT (molecular Nanotechnology) from the perspective of an experimental nanoscientist, focussing in particular on the aims and objectives of a recently-funded programme of work on computer-controlled assembly of diamond nanostructures, e.g. via mechanosynthesis
Leonid Gavrilov Chicago, USA
Demographic consequences of defeating aging
Even for very long 50-year projection horizon [with defeat of aging], with the most radical life extension scenario (assuming no aging at all after age 50), the total population increases by 35 percent only (from 9.1 to 13.3 billion).
http://longevity-science.blogspot.com/
Nickolas Mayer Satellite Beach, USA
The Lifenaut Project: a multifaceted experiment in data storage for future machine consciousness learning
The goal of the Lifenaut Project has been to create a diverse, large-scale database consisting of real people’s personality archives such that future intelligent agents can learn rapidly by uploading archived data rather than experiencing events in real time. A learning protocol such as this would increase the rate of progress in the field of machine consciousness and may be more effectively tested than real time learning protocols, since in many cases a frame of reference will exists for comparison with the replicated consciousness.
A web-based personality archiving architecture (lifenaut.com) has been created and promoted to the general public as such. Through this web-based interface anyone worldwide with an internet connection can create a “mindfile” free of charge. The mindfile consists of: personality test results, personal profile data, uploaded biographical media, and an archive of the user’s lines of conversation with a chatbot. Since its kickoff in 2006, Lifenaut has undergone 3 major iterations and each user’s mindfile is tapped into the iCogno chatbot engine combined with an InterMediaLab photo-based avatar. At the time of this writing 8,702 from around the globe have created Lifenaut accounts. Agents resulting from long-term user interaction with the Lifenaut software will be tested with the ConsScale 2 consciousness taxonomy (Arrables-Moreno).
Other Sessions
Sept 4, 2009
Session 5 Eliminating recalcitrant intracellular molecules: the lysosome (Chair: Alex Whitworth)
Session 6 Eliminating recalcitrant intracellular molecules: other (Chair: Ana Maria Cuervo)
Session 7 Panel discussion and short talks (Chair: John Furber)
Session 8 Short talks (Chair: Alex Zhavoronkov)
Session 9 Rejuvenating extracellular material: amyloid (Chair: Kendall Houk)
Session 10 Rejuvenating extracellular material: other (Chair: Nik Nikitin)
Sept 5, 2009
Session 11 Telomeres and telomerase (Chair: Cassian Yee)
Maria Blasco Madrid, Spain
Role of Shelterin in Cancer and Aging
Vera Gorbunova Rochester, USA
Evolution of anticancer mechanisms in short- and long-lived species
David Keefe Tampa, USA
Telomeres and Reproductive Aging
Session 12 Novel anti-cancer approaches (Chair: Vera Gorbunova)
Paul Hallenbeck Malvern, USA
Phase I study of Seneca Valley Virus (SVV-001), a replication competent oncolytic virus, in patients with neuroendocrine (NE) cancers
Adela Ben-Yakar Austin, USA
Femtosecond laser nanosurgery from shedding light on nerve regeneration to aiding in cancer diagnosis and therapy
Cassian Yee Seattle, USA
Engineering Tumor Immunity: Adoptive T Cell Therapy of Cancer
Session 13 SENS Lecture and short talks (Chair: Silvia Gravina)
Moses Znaimer Toronto, Canada
SENS Lecture: Canada – Harbinger of the Zoomer Phenomenon (Chair: Aubrey de Grey)
Natalia Gavrilova Chicago, USA
Search for mechanisms of exceptional human longevity
Mike Berridge Wellington, New Zealand
Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect
Ülo Kristjuhan Tallinn, Estonia
Postponed Aging in University Teachers
Session 14 Short talks (Chair: Mike Berridge)
Session 15 Rejuvenating the immune system (Chair: Lusine Danielyan)
Janko Nikolich-Zugich Beaverton, USA
Why T-cells go out of whack with aging and what to do about it
Anne de Groot Providence, USA
Re-establishing Immunological Balance and Re-engineering Tolerance with Tregitopes
Omar Ali Cambridge, USA
Infection-mimicking materials to program dendritic cells in situ
Justin Rebo
SENS Foundation Research Center Senescent T cell removal using magnetic antibodies
Session 16 Delivering genes, proteins and larger structures in vivo (Chair: Janko Nikolich-Zugich)
Dieter Willbold Düsseldorf, Germany
Oral treatment with an Aβ42 oligomer modulating D-amino acid peptide improves cognitive behavior of APP/ PS1 double transgenic mice
Lusine Danielyan Tübingen, Germany
Intranasal delivery of cells to the brain
Carlos Barbas La Jolla, USA
Synthesis of programmable integrases
Sunday 6th September
Session 17 Novel routes to the ES-like phenotype (Chair: Daniel Kraft)
Justin Ichida Cambridge, USA
Reprogramming Somatic Cells to Pluripotency Using Small Molecules
Ilham Abuljadayel London, UK
Retrodifferentiation and Aging: Harnessing Youth through Induction of Pluripotency in mature adult cells via Cell Surface Receptor Contact
Khachik Muradian Kiev, Ukraine
“ORION” – a glimpse of hope in life span extension?
Vadim Fraifeld Beer-Sheva, Israel
MicroRNA-regulated protein-protein interaction networks: how could they help in searching for pro-longevity targets?
Session 18 Recent advances in cell therapies (Chair: Ilham Abuljadayel)
Daniel Kraft Stanford, USA
Manipulation and Derivation of the Hematopoitic Stem Cell Niche
Gene Redmond Thousand Oaks,
USA Cellular repair in the non-human primate brain with human neural stem cells and multiple fetal cells grafts.
Hadi Aslan Jerusalem, Israel
Engineered Mesenchymal Stem Cells – The Road to Skeletal Tissue Regeneration
Session 19 Panel discussion and short talks (Chair: James Morré)
James Larrick Sunnyvale, USA
Panel Discussion: Applied Healthspan Engineering
Dazhong Yin Guangzhou, China
Preventive Treatment of Traditional Chinese Medication as Anti-stress and Anti-aging Strategy
Jwala Sinha Palamau, India
Strategies for adjustment of the aged
John Furber Gainesville, USA
Extracellular Aging: Issues for Therapy Design
Session 20 Short talks (Chair: James Larrick)
Gunther Kletetschka Greenbelt, USA
Crack avoidance during cryopreservation attempts
Sonya Vasto Palermo, Italy
Parental longevity impacts on the healthy ageing of their offspring: Effects on blood and clinical chemistry parameters in centenarians’ offspring
Noel Patton New York, USA
Recent progress in pharmacological amelioration of telomere shortening
David Williams Cambridge, UK
Cataract development as a model of ageing – a comparative approach
Michael Colgan Salt Spring Island, Canada
Combined chemical and brain stimulation induction of neurogenesis in brain injury and brain degeneration of aging.
D. James Morré West Lafayette, USA
Aging related NADH oxidase (arNOX) response to dietary supplementation . The French Paradox revisited
Joshua Mitteldorf Philadelphia, USA
Accumulated Damage is not the Root Cause of Aging
Open source Database Breakthrough: 10-80 times faster
Cadence integrates chip planning with implementation!
Cadence has called this breakthrough solution, which provides design and implementation engineers with superior visibility and predictability of chip performance, area, power consumption, cost, and time to market across the full range of design activities, including system-level design and IP selection through final implementation and signoff.
I got into a brief conversation with Adam Traidman, Group Marketing Director, Cadence, Dave Desharnais, Product Marketing Group Director, Cadence, and Rahul Arya, Director, Marketing & Technology Sales, Cadence Design Systems India Pvt Ltd.
Why this solution?
The obvious question, why the Integrated Chip Planning and Implementation Solution now?
Adam Traidman said that the Chip Estimator is quite unique! It helps customers early in the IC design cycle.
“We go beyond EDA and estimate cost, etc. We help the designers to do an early architectural level ecomnomical and techical analysis and estimation, etc. Statistics show that during the early phases of design, those decisions can contribute to 80 percent of final design. Today, very few EDA companies provide set of tools and methodologies that allow such trade-off,” he added.
According to him, every customer does this analysis, probably, manually. Cadence is now automating this method. In this respect, it has integrated chip planning with implementation.
“The results of the analysis — you are concerned about accuracy; you look to the EDA vendors to help converge from initial implementation to the actual convergence. Think of it like a cockpit for the design engineer, general manager, program manager, etc.,” he noted.
“You’ve made all the fundamental decisions, etc. If you’re sitting on the physical implementation tool, and you need think through the implications that can be there. For example, to re-synthesize new libraries, etc. We are talking about chip planning at a much, much higher level,” added Traidman.
Helping with IP selection!
The Cadence solution also leverages the vast ecosystem of IP at the ChipEstimate.com portal where over 200 IP suppliers and foundries contribute data. Helping with IP selection has been mentioned among the processes, perhaps, an indicator that designers may have not been able to select the right IPs all this while.
According to Traidman, IP selection and qiuality are key issues. “A lot of people, doing these tradeoffs, could be design managers, general manager, etc. When they sit with this tool, and when it pops up, they can see a huge library of 7,000 IPs from about 200 IP suppliers and foundries. Any design team can view all of the IPs as a free service,” he elaborated. By the way, ChipEstimate is owned by Cadence!
He further added that the ChipEstimate portal allows customers to lower the risks of converging. The portal has been growing since 2006, and receives 1 million page view each month.
Just for interest’s sake, there’s another site — Design And Reuse — that claims to be the world’s largest directory of 8,000 silicon IPs from more than 400 vendors! I have also got into some other discussions — that are ongoing — for developing a similar site in India, for the Indian semiconductor industry!
What about Cadence Encounter?
Post the integration, what happens now to the Cadence Encounter solution and whether it is still available standalone?
Dave Desharnais said the Cadence Encounter solution is still available standalone. “We have integrated some key functions from InCyte. From InCyte, you would normally not have the link to get into physical implementation. Likewise, with feeding back of a fully realized database,” he said.
Last December (2008), Cadence had announced the Encounter Digital Implementation System, a next generation complete RTL-to-GDSII solution for logic and physical implementation.
Along with a fundamental new memory architecture and end-to-end multicore backplane to address the requirements of leapfrog capacity and faster turnaround time for billion transistor designs, it also delivers complete implementation and signoff-in-the-loop for low power, mixed signal, and advanced node design; including the latest 28nm process node where it has been used on over half of the designs being done at this node today.
As per Rahul Arya, since the initial launch, there has been significant usage and endorsement from the world’s largest semiconductor companies, including ST, Toshiba, NEC, NXP, Fujitsu, AMD, and many more that are requested as non-public endorsements.
He added: “The announcement of InCyte and EDI System integration brings a whole new dimension for both system-level and design implementation teams. While both solutions — InCyte and EDI System — are still available as standalone, using both solutions together enables designers at all levels to now have complete visibility into all aspects of the design — from system level architecture requirements and IP selection, to full physical floorplanning, final low power and implementation signoff results.
“The bringing together of both of these solutions delivers literally unprecedented predictability, visibility, and accuracy into all steps of the chip creation and implementation flow for faster design convergence.”
The design solution will be demonstrated at the Design Automation Conference (DAC 2009) in San Francisco this month and made available later this year.
Idaho National Labs Makes Key Progress for Enabling Fourth Generation Nuclear Reactors

Key milestones have been passed after three years of planning, machining, wiring and welding, in the progress of the Advanced Graphite Capsule project. This six-phase project will test over 2,000 different samples of graphite in INL’s Advanced Test Reactor facility over a roughly 10-year period that will last until 2020.
Today, nuclear experts envision two different versions of gas cooled VHTRs for next-generation use. Both designs will require large amounts of high-quality graphite.
The “pebble-bed” style reactor uses billiard-ball-size “pebbles” of nuclear fuel particles coated with several layers of silicon-carbide and carbon. The pebbles enter the reactor from the top, work their way down through and exit the reactor from the bottom. There, they are monitored for remaining fuel to make another pass. Or, if the useable fuel is consumed by the time it reaches the bottom, it is collected for disposal. A second design utilizes a honeycomb block of graphite into which fuel rods would be inserted.
A critical step in developing new Very High Temperature Reactors (VHTR) is certifying the graphite that is used in many parts of the reactor’s core. Take the welding, for example. On the 14-foot section of the capsule that will be entered into the reactor core, 13 super precise welds cause less than twenty-thousandths of an inch in variation from one end of the capsule to the other.
With the capsule finished and inspected, it will enter INL’s Advanced Test Reactor in June. There, it will endure average temperatures of 600 degrees Celsius (six times the temperature of boiling water) for almost two years. Five similar Advanced Graphite Capsule experiments will follow the first one.
The capsules will be exposed to successively increased temperatures so the last capsule will experience temperatures of over 1,200 degrees Celsius. Experimenters will also expose the samples to varying levels of radiation, all several times what they would experience in a normal reactor. The higher radiation levels give researchers a sense of how the material will behave under the prolonged irradiation the graphite would experience over many years in a next-generation reactor.
After data from each test is gathered and each capsule is removed from the reactor, more work awaits the team. Post Irradiation Examination will involve removing the graphite samples and measuring and recording the differences in each one’s characteristics compared to before its trip to the reactor.
Every detail of the half-inch diameter samples will be considered. Researchers will construct a new database after measuring how the irradiation changed the physical dimensions of the pieces, examining their “thermal diffusivity” using lasers, and recording other specifications.
This information will allow those who build advanced nuclear reactors to be sure that communities will, for generations, reap the benefits of clean, safe, inexpensive and abundant energy to power their progress


